<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>

<channel>
	<title>Lew Rakowsky</title>
	<atom:link href="http://www.lewrakowsky.com/feed" rel="self" type="application/rss+xml" />
	<link>http://www.lewrakowsky.com</link>
	<description></description>
	<pubDate>Fri, 11 Sep 2009 15:18:36 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.3</generator>
	<language>en</language>
			<item>
		<title>Coppervale Identity and Website</title>
		<link>http://www.lewrakowsky.com/work/greentechnology/coppervale-identity-and-website</link>
		<comments>http://www.lewrakowsky.com/work/greentechnology/coppervale-identity-and-website#comments</comments>
		<pubDate>Mon, 23 Mar 2009 17:06:29 +0000</pubDate>
		<dc:creator>lew</dc:creator>
		
		<category><![CDATA[Green Technology]]></category>

		<guid isPermaLink="false">http://www.lewrakowsky.com/?p=220</guid>
		<description><![CDATA[Coppervale Identity and Website
Problem
Coppervale is a start-up consulting enterprise that offers comprehensive renewable energy and conservation strategies for clients worldwide. In this highly-competitive market, Coppervale quickly needed to build awareness of its existence.
Solution
Create an unique identity, develop a message architecture and launch an online presence
anchored in issues and needs common to global professionals and their [...]]]></description>
			<content:encoded><![CDATA[<div id="case" style="margin-right:152px;">Coppervale Identity and Website</div>
<p id="largeIndent"><strong>Problem</strong><br />
Coppervale is a start-up consulting enterprise that offers comprehensive renewable energy and conservation strategies for clients worldwide. In this highly-competitive market, Coppervale quickly needed to build awareness of its existence.</p>
<p><strong>Solution</strong><br />
Create an unique identity, develop a message architecture and launch an online presence<br />
anchored in issues and needs common to global professionals and their organizations.</p>
<p>Role: creative director, strategist and designer<br />
Credit: in collaboration with <a href="http://www.tomdevine.com/">Tom Devine</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.lewrakowsky.com/work/greentechnology/coppervale-identity-and-website/feed</wfw:commentRss>
		</item>
		<item>
		<title>California Association to Aid Ukraine Rebranding</title>
		<link>http://www.lewrakowsky.com/work/nonprofit/caau</link>
		<comments>http://www.lewrakowsky.com/work/nonprofit/caau#comments</comments>
		<pubDate>Sat, 21 Mar 2009 21:22:36 +0000</pubDate>
		<dc:creator>lew</dc:creator>
		
		<category><![CDATA[Non-Profit]]></category>

		<guid isPermaLink="false">http://www.lewrakowsky.com/?p=180</guid>
		<description><![CDATA[California Association to Aid Ukraine Rebranding
Problem
CAAU coordinates local support of many development projects in Ukraine, including education, culture, health care and politics. The organization&#8217;s efforts have evolved from offering much-needed relief during the post-Soviet period to investing in projects that will have long-lasting impact.
Solution
Create a new identity to reflect a more sophisticated approach to philanthropy.
Develop [...]]]></description>
			<content:encoded><![CDATA[<div id="case" style="margin-right:152px;">California Association to Aid Ukraine Rebranding</div>
<p id="largeIndent"><strong>Problem</strong><br />
CAAU coordinates local support of many development projects in Ukraine, including education, culture, health care and politics. The organization&#8217;s efforts have evolved from offering much-needed relief during the post-Soviet period to investing in projects that will have long-lasting impact.</p>
<p><strong>Solution</strong><br />
Create a new identity to reflect a more sophisticated approach to philanthropy.<br />
Develop a communication strategy to reach more potential contributors.</p>
<p>Role: creative director and designer</p>
]]></content:encoded>
			<wfw:commentRss>http://www.lewrakowsky.com/work/nonprofit/caau/feed</wfw:commentRss>
		</item>
		<item>
		<title>Enbrel Exhibit at AAD</title>
		<link>http://www.lewrakowsky.com/work/healthcare/enbrel-exhibit</link>
		<comments>http://www.lewrakowsky.com/work/healthcare/enbrel-exhibit#comments</comments>
		<pubDate>Sun, 03 Feb 2008 20:58:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.lewrakowsky.com/exhibits/sensipar-launch-meeting</guid>
		<description><![CDATA[Enbrel Exhibit at AAD
Problem
In 2005, Enbrel became a market leader, less than one year after launching. The upcoming annual meeting of the American Academy of Dermatology (AAD) would be an opportunity to share this news. So, how do you translate market leadership in an exhibit space?
Solution
Create a total experience for attendees.
Role: creative director
Credit: in collaboration [...]]]></description>
			<content:encoded><![CDATA[<div id="case" style="margin-right:152px;">Enbrel Exhibit at AAD</div>
<p id="largeIndent"><strong>Problem</strong><br />
In 2005, Enbrel became a market leader, less than one year after launching. The upcoming annual meeting of the American Academy of Dermatology (AAD) would be an opportunity to share this news. So, how do you translate market leadership in an exhibit space?</p>
<p><strong>Solution</strong><br />
Create a total experience for attendees.</p>
<p>Role: creative director<br />
Credit: in collaboration with <a href="http://www.accesstca.com/">Access TCA, <a href="http://www.arkmediainc.com/">Ark Media</a> and <a href="http://www.bdainc.com/">Bensussen Deutsch &#038; Associates</a>.<br />
</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.lewrakowsky.com/work/healthcare/enbrel-exhibit/feed</wfw:commentRss>
		</item>
		<item>
		<title>Denosumab Exhibit at ASBMR</title>
		<link>http://www.lewrakowsky.com/work/healthcare/denosumab-exhibit</link>
		<comments>http://www.lewrakowsky.com/work/healthcare/denosumab-exhibit#comments</comments>
		<pubDate>Mon, 28 Jan 2008 00:25:24 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://d3p0.com/temp/identities/sample-3</guid>
		<description><![CDATA[Denosumab Exhibit at ASBMR
Problem
Denosumab is a investigational drug that has the potential of transforming osteoporosis treatment. Though FDA approval was still years away, Amgen wished to raise awareness in the medical community about this novel molecule. 
Solution
Create an exhibit at the annual meeting of the American Society of Bone and
Mineral Research (ASBMR) to share the [...]]]></description>
			<content:encoded><![CDATA[<div id="case" style="margin-right:152px;">Denosumab Exhibit at ASBMR</div>
<p id="largeIndent"><strong>Problem</strong><br />
Denosumab is a investigational drug that has the potential of transforming osteoporosis treatment. Though FDA approval was still years away, Amgen wished to raise awareness in the medical community about this novel molecule. </p>
<p><strong>Solution</strong><br />
Create an exhibit at the annual meeting of the American Society of Bone and<br />
Mineral Research (ASBMR) to share the latest scientific understanding of the<br />
disease pathway in which denosumab plays a critical role.</p>
<p>Role: creative director and strategist<br />
Credit: in collaboration with <a href="http://www.accesstca.com/">Access TCA</a>, <a href="http://www.hornallanderson.com/">Hornall Anderson</a> and <a href="http://www.clinedavis.com/">CDM</a>
</p>
<div class="both"></div>
]]></content:encoded>
			<wfw:commentRss>http://www.lewrakowsky.com/work/healthcare/denosumab-exhibit/feed</wfw:commentRss>
		</item>
		<item>
		<title>Finish First: Sensipar Launch Meeting</title>
		<link>http://www.lewrakowsky.com/work/healthcare/sensipar-launch</link>
		<comments>http://www.lewrakowsky.com/work/healthcare/sensipar-launch#comments</comments>
		<pubDate>Mon, 28 Jan 2008 00:25:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://d3p0.com/temp/exhibits/sample-2</guid>
		<description><![CDATA[Finish First: Sensipar Launch Meeting

Problem
Sensipar is an important medicine for kidney dialysis patients who suffer from a serious metabolic disorder. With FDA approval anticipated soon, the Sensipar brand team knew it was critical to prepare the sales team appropriately so that they are energized and confident to sell Sensipar.
Solution
The launch was divided into three meetings. [...]]]></description>
			<content:encoded><![CDATA[<div id="case" style="margin-right:152px;">Finish First: Sensipar Launch Meeting</div>
<p id="largeIndent">
<strong>Problem</strong><br />
Sensipar is an important medicine for kidney dialysis patients who suffer from a serious metabolic disorder. With FDA approval anticipated soon, the Sensipar brand team knew it was critical to prepare the sales team appropriately so that they are energized and confident to sell Sensipar.</p>
<p><strong>Solution</strong><br />
The launch was divided into three meetings. Two training meetings, for managers<br />
and sales reps respectively, were held in advance so that the sales teams would<br />
arrive at the launch meeting prepared, confident, and excited.</p>
<p>Role: design director<br />
Credit: in collaboration with <a href="http://www.jackmorton.com/">Jack Morton Worldwide</a> and <a href="http://www.hcassociates.com/">Hamagami/Carroll</a>
</p>
<div class="both"></div>
]]></content:encoded>
			<wfw:commentRss>http://www.lewrakowsky.com/work/healthcare/sensipar-launch/feed</wfw:commentRss>
		</item>
		<item>
		<title>By My Side Chemotherapy Starter Kit</title>
		<link>http://www.lewrakowsky.com/work/healthcare/by-my-side</link>
		<comments>http://www.lewrakowsky.com/work/healthcare/by-my-side#comments</comments>
		<pubDate>Mon, 28 Jan 2008 00:25:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://d3p0.com/temp/events/sample</guid>
		<description><![CDATA[Helping patients help themselves.

Problem
Amgen’s supportive care products changed oncology practice. But newly-diagnosed cancer patients need access to more than just medicine. How do you give them the information they need?
Solution
Design a starter kit that provides patients and their caregivers with tools and resources to help them through their treatment journey.
Role:  Design director
Credit:  in [...]]]></description>
			<content:encoded><![CDATA[<div id="case" style="margin-right:152px;">Helping patients help themselves.</div>
<p id="largeIndent">
<strong>Problem</strong><br />
Amgen’s supportive care products changed oncology practice. But newly-diagnosed cancer patients need access to more than just medicine. How do you give them the information they need?</p>
<p><strong>Solution</strong><br />
Design a starter kit that provides patients and their caregivers with tools and resources to help them through their treatment journey.</p>
<p>Role:  Design director<br />
Credit:  in collaboration with <a href="http://www.bdainc.com/index.html"><a href="http://www.bdainc.com/index.html">Bensussen Deutsch &#038; Associates</a></a>. Illustrations by <a href="http://www.zocolo.com/Artist.asp?ArtistID=21898&#038;Akey=AB782ELR">Nicholas Wilton</a>.
</p>
<div class="both"></div>
]]></content:encoded>
			<wfw:commentRss>http://www.lewrakowsky.com/work/healthcare/by-my-side/feed</wfw:commentRss>
		</item>
		<item>
		<title>Amgen Oncology Communications Identity Guidelines</title>
		<link>http://www.lewrakowsky.com/work/healthcare/oncology-identity</link>
		<comments>http://www.lewrakowsky.com/work/healthcare/oncology-identity#comments</comments>
		<pubDate>Sun, 27 Jan 2008 21:06:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://d3p0.com/temp/?p=1</guid>
		<description><![CDATA[Amgen Oncology Communications Identity Guidelines

Problem
As Amgen&#8217;s commercial oncology product portfolio grew, its medical education, corporate licensing and other non-promotional programs lacked a coordinated strategy to keep pace. The materials looked fragmented and confusing, and did not leverage any of the brand&#8217;s equity. 
Solution
Create a unified design system with clear guidelines, proprietary art assets and
turn-key templates.
Role: [...]]]></description>
			<content:encoded><![CDATA[<div id="case" style="margin-right:152px;">Amgen Oncology Communications Identity Guidelines</div>
<p id="largeIndent">
<strong>Problem</strong><br />
As Amgen&#8217;s commercial oncology product portfolio grew, its medical education, corporate licensing and other non-promotional programs lacked a coordinated strategy to keep pace. The materials looked fragmented and confusing, and did not leverage any of the brand&#8217;s equity. </p>
<p><strong>Solution</strong><br />
Create a unified design system with clear guidelines, proprietary art assets and<br />
turn-key templates.</p>
<p>Role: Design director<br />
Credit: in collaboration with <a href="http://www.hcassociates.com/">Hamagami/Carroll</a>
</p>
<div class="both"></div>
]]></content:encoded>
			<wfw:commentRss>http://www.lewrakowsky.com/work/healthcare/oncology-identity/feed</wfw:commentRss>
		</item>
		<item>
		<title>Clinical Trial Patient Recruitment Program</title>
		<link>http://www.lewrakowsky.com/work/healthcare/denosumab-clinical-trial-20050147-integrated-communications-program</link>
		<comments>http://www.lewrakowsky.com/work/healthcare/denosumab-clinical-trial-20050147-integrated-communications-program#comments</comments>
		<pubDate>Thu, 27 Apr 2006 05:41:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
		
		<category><![CDATA[Health Care]]></category>

		<guid isPermaLink="false">http://www.lewrakowsky.com/work/denosumab-clinical-trial-20050147-integrated-communications-program</guid>
		<description><![CDATA[Clinical trial now enrolling.

Problem
What if you launched a clinical trial and no one enrolled?
What if the future of your company depended on its success?
Solution
To overcome this challenge, Amgen deployed a collaborative group
of internal and external teams to help. The result was an integrated
marketing communications program that dramatically increased the
number of eligible patients matched to clinics.
Role: [...]]]></description>
			<content:encoded><![CDATA[<div id="case" style="margin-right:152px;">Clinical trial now enrolling.</div>
<p id="largeIndent">
<strong>Problem</strong><br />
What if you launched a clinical trial and no one enrolled?<br />
What if the future of your company depended on its success?</p>
<p><strong>Solution</strong><br />
To overcome this challenge, Amgen deployed a collaborative group<br />
of internal and external teams to help. The result was an integrated<br />
marketing communications program that dramatically increased the<br />
number of eligible patients matched to clinics.</p>
<p>Role:  Creative strategist<br />
Credit:  in collaboration with <a href="http://www.hornallanderson.com/">Hornall Anderson</a> and <a href="http://www.clinedavis.com/">CDM</a>.
</p>
<div class="both"></div>
]]></content:encoded>
			<wfw:commentRss>http://www.lewrakowsky.com/work/healthcare/denosumab-clinical-trial-20050147-integrated-communications-program/feed</wfw:commentRss>
		</item>
	</channel>
</rss>
